Effect of Vaginal PH on Treatment Effectiveness With Misoprostol for First Trimester Missed Abortions
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2011 by HaEmek Medical Center, Israel.
Recruitment status was Not yet recruiting
Recruitment status was Not yet recruiting
Sponsor:
HaEmek Medical Center, Israel
Information provided by:
HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier:
NCT01270334
First received: January 4, 2011
Last updated: NA
Last verified: January 2011
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
vaginal PH has an effect on the effectiveness of treatment with misoprostol given vaginally for missed abortions in the first trimester
| Condition | Intervention |
|---|---|
|
MISED ABORTION- Vaginal PH |
Other: PH meassurment |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Effect of Vaginal PH on Treatment Effectiveness With Misoprostol for First Trimester Missed Abortions |
Resource links provided by NLM:
Further study details as provided by HaEmek Medical Center, Israel:
Primary Outcome Measures:
- treatment failure- need for D&C [ Time Frame: 2 weeks ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- side effects, need foe analgetics, time for compliting abortion [ Time Frame: 2 weeks ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 400 |
| Study Start Date: | February 2011 |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| ph above cutoff |
Other: PH meassurment
meassuring ph USING PROBE
|
| PH under cutoff |
Other: PH meassurment
meassuring ph USING PROBE
|
Eligibility| Ages Eligible for Study: | 18 Years to 50 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
women dignosed with missed abortion in the first trimester
Criteria
Inclusion
- missed abortion under 8 weeks by sac diameter over 18 years old informed concent given
Exclusion Criteria:
- missed abortion over 8 weeks hypersensitivity for PG vaginal bleeding suspected EUP IUD heart disease, HTN, cerebral vascular disease, epilepsy intrauterine infection clooting disorder under 18
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01270334
Contacts
| Contact: shira baram, dr | 972-4-6494035 | shira_ba@clalit.org.il |
Locations
| Israel | |
| Haemel Medical Center | Not yet recruiting |
| Afula, Israel | |
| Contact: shira baram, md 972-4-6494035 | |
| Principal Investigator: shira baram, md | |
Sponsors and Collaborators
HaEmek Medical Center, Israel
More Information
No publications provided
| Responsible Party: | doctor baram shira, HaEmek Medical Center |
| ClinicalTrials.gov Identifier: | NCT01270334 History of Changes |
| Other Study ID Numbers: | cytoph |
| Study First Received: | January 4, 2011 |
| Last Updated: | January 4, 2011 |
| Health Authority: | Israel- Health ministery, Israel: |
Additional relevant MeSH terms:
|
Abortion, Missed Abortion, Spontaneous Pregnancy Complications Misoprostol Anti-Ulcer Agents Gastrointestinal Agents Therapeutic Uses |
Pharmacologic Actions Oxytocics Reproductive Control Agents Physiological Effects of Drugs Abortifacient Agents, Nonsteroidal Abortifacient Agents |
ClinicalTrials.gov processed this record on May 19, 2013